The funding has allowed us to pursue pre-clinical evaluation of our anticoagulant and reversal agent.
"As a land-grant university, our mission is to positively impact the lives of the residents of North Carolina and beyond by commercializing state-of-the-art research to solve societal problems," says Wade Fulghum, Assistant Vice Chancellor of the Office of Research Commercialization. "The Chancellor's Innovation Fund - which has a very successful 10-year track record, generating $18 in additional research funding or investment for every dollar awarded - plays a critical role by providing funding to translate technologies to a point where a startup can be formed for commercialization or a license can be executed with an existing company."